Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
基本信息
- 批准号:10058976
- 负责人:
- 金额:$ 91.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-24 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibodiesAreaBaltimoreBasic ScienceBiomedical ResearchCell Culture TechniquesClinicalCollaborationsCommunitiesCountryDisciplineDiseaseDisease ProgressionEnd stage renal failureFutureGap JunctionsGenerationsGoalsInstitutionInterdisciplinary StudyKnowledgeLeadershipMarylandMissionNational Institute of Diabetes and Digestive and Kidney DiseasesPolycystic Kidney DiseasesReagentResearchResearch PersonnelResourcesScienceSignal TransductionStretchingStudentsTherapeuticTherapeutic AgentsTranslational ResearchTranslationsUniversitiesVisionbasebiobankcellular engineeringclinical investigationclinical translationexperienceinnovationinterdisciplinary collaborationmedical schoolsmouse modelpreventprospectiveside effectsuccesstherapeutic targetvector
项目摘要
Overall Project Summary
In this application we establish the Maryland Polycystic Kidney Disease (PKD) Research and Translation Core
Center (MPKD-RTCC). The mission of this Center is to facilitate translational and basic research in the field of
polycystic kidney disease and related disciplines by providing unique resources, reagents and expertise to a
broad base of investigators. This proposal capitalizes on a long tradition of PKD research by MPKD-RTCC
investigators who have been at the forefront of PKD science for the past two decades. The Center consists of
4 highly collaborative and integrated biomedical research cores that together will distribute an essential
“toolbox” of reagents and expertise tailored specifically to PKD research. The MPKD-RTCC cores include 1)
Antibody and Vector 2) Mouse Models and Biobank 3) Cell Culture and Engineering and 4) Clinical and
Translation. Each core addresses a critical need in the PKD research pipeline, stretching from basic to clinical
investigation. In addition, MPKD-RTCC core leaders will pioneer solutions to perceived needs among PKD
Researchers by expanding in innovative directions. We expect that this strategy will continue our proven track
record of supporting high impact science across the country. These activities will be organized by an
Administrative Core led by two experienced investigators who will leverage the resources of two outstanding
research institutions in Baltimore, the University of Maryland Baltimore (UMB) and the Johns Hopkins School
of Medicine. As a team they will drive the MPKD-RTCC’s fundamental commitment to the principle of
collaborative science by streamlining SOPs for sharing high quality reagents and expertise, by integrating our
the core’s activities and by coordinating collaboration with other RTCCs within the PKD Research Consortium.
The Center’s Specific Aims are: 1) To provide critical state of the art reagents and expertise to a national group
of PKD investigators 2) To provide critical state of the art reagents and expertise to non-PKD investigators in
order to remove barriers to PKD related research 3) To develop innovative reagents and resources that will
advance biomedical discoveries in the field of PKD 4) To drive collaboration between MPKD-RTCC Cores and
other RTCCs within the PKD Research Consortium and 5) To partner with other RTCCs, the consortium
steering committee including the NIDDK to achieve the overall goals of the PKD Research Consortium.
Through expanded interdisciplinary collaborations, we hope to catalyze the translation of biomedical
discoveries that will prevent progression of polycystic kidney disease and its consequences.
整体项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Terry J Watnick其他文献
Terry J Watnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Terry J Watnick', 18)}}的其他基金
Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
- 批准号:
10693919 - 财政年份:2020
- 资助金额:
$ 91.97万 - 项目类别:
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
国家多囊肾病 (PKD) 研究和转化核心中心协调中心 (NCC)
- 批准号:
10218161 - 财政年份:2020
- 资助金额:
$ 91.97万 - 项目类别:
Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
- 批准号:
10231255 - 财政年份:2020
- 资助金额:
$ 91.97万 - 项目类别:
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
国家多囊肾病 (PKD) 研究和转化核心中心协调中心 (NCC)
- 批准号:
10687258 - 财政年份:2020
- 资助金额:
$ 91.97万 - 项目类别:
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
国家多囊肾病 (PKD) 研究和转化核心中心协调中心 (NCC)
- 批准号:
10058889 - 财政年份:2020
- 资助金额:
$ 91.97万 - 项目类别:
Administrative Supplement to Watnick U54DK126114
Watnick U54DK126114 的行政补充
- 批准号:
10688699 - 财政年份:2020
- 资助金额:
$ 91.97万 - 项目类别:
Maryland Polycystic Kidney Disease Research and Translation Core Center (MPKD-RTCC)
马里兰州多囊肾病研究与转化核心中心 (MPKD-RTCC)
- 批准号:
10456638 - 财政年份:2020
- 资助金额:
$ 91.97万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 91.97万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 91.97万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 91.97万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 91.97万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 91.97万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 91.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 91.97万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 91.97万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 91.97万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 91.97万 - 项目类别: